mapping the effectiveness and risks of glp 1 Glucagon-like peptide-1 receptor agonists risk substance use disorders among US veterans with type 2 diabetes: cohort study Mapping the effectiveness and risks

Adjust portions based on hunger, tolerance, and individual protein targets

Hypochlorous acid has a protective effect on pathogens and their intermediates

Polyunsaturated fatty acids and inflammatory processes: New twists in an old tale

That is very specific (and odd since, though we know BMI is a terrible measure of health, it is at least clear and overweight starts at 25, so its pretty odd that they chose to start at 27.) Especially given the ways that they manipulated the media, healthcare system, and public about the results, we have to wonder if/how they are manipulating the studies themselves

Highlights of Prescribing Information: Metformin hydrochloride tablets, for oral use

Initially developed for treating type 2 diabetes, their remarkable impact on weight loss soon became apparent